VYNE Therapeutics Inc. announced that Andrew Saik tendered his resignation from his role as Treasurer. Mr. Saik joined VYNE in March 2020 following the transaction which combined the businesses of Foamix Pharmaceuticals Ltd. and Menlo Therapeutics Inc. The Company has named Tyler Zeronda currently Vice President of Finance of the Company, to serve as Treasurer of VYNE effective as of June 18, 2021 until a permanent replacement is named. In this role Mr. Zeronda will serve as the Company’s Principal Financial Officer and Principal Accounting Officer. Mr. Zeronda joined Foamix in April 2019 and has been responsible for all finance activities related to the commercial operations, financial planning, treasury, risk management and supply chain matters of the Company.